Endocrinology Practice Questions

Q: A 63-year-old female with a history of osteoporosis presents with worsening back pain and weight loss. MRI shows multiple vertebral fractures and compression deformities. Which treatment option is most appropriate for this patient?

Initiate bisphosphonates to reduce further bone loss. ***Initiate bisphosphonates to reduce further bone loss*** - Bisphosphonates are **first-line therapy** for osteoporosis, especially in patients with **vertebral fractures**, as they reduce bone resorption and the risk of future fractures [1]. - While weight loss and multiple fractures might raise concern for other etiologies, addressing the established **osteoporosis** with proven anti-resorptive therapy is the immediate and most appropriate step. *Calcium and vitamin D supplementation, defer further treatment* - While essential for bone health, **calcium and vitamin D supplementation alone** is insufficient to treat severe osteoporosis with existing vertebral fractures [1]. - Deferring further specific treatment for osteoporosis would leave the patient at **high risk for additional fractures** and worsening pain and disability [1]. *Spinal surgery, then reassess bone health* - **Spinal surgery** is considered for specific indications such as **spinal instability**, neurological compromise, or intractable pain not responding to conservative management, which are not explicitly mentioned as primary concerns. - Addressing the underlying **osteoporosis** with medication is crucial regardless of surgical intervention, as surgery does not treat the systemic bone disease. *Start anabolic agents like teriparatide to build bone mass* - **Anabolic agents like teriparatide** are potent therapies that stimulate bone formation and are highly effective; however, they are typically reserved for patients with very severe osteoporosis, those who have failed bisphosphonate therapy, or those with very high fracture risk. - Given the established osteoporosis and new fractures, initiating **bisphosphonates** is the more common and generally recommended initial approach before considering more specialized anabolic agents.

Q: A patient with a history of radiation exposure presents with fatigue and weight loss. Which hormone deficiency is most commonly associated with cranial radiation therapy?

Growth hormone deficiency. **Growth hormone deficiency** - The **somatotrophs** in the pituitary gland, which produce growth hormone, are the most sensitive to the effects of **radiation therapy**, making growth hormone deficiency the earliest and most common endocrine abnormality to develop after cranial radiation. - Symptoms such as **fatigue** and **weight loss** can be manifestations of growth hormone deficiency, although they are nonspecific and require further investigation. *Prolactin deficiency* - While prolactin-producing cells (lactotrophs) can be affected by radiation, **prolactin deficiency** is less common than growth hormone deficiency and typically presents with symptoms related to lactation failure. - There is no strong direct association between prolactin deficiency and the presented symptoms of fatigue and weight loss. *Gonadotropin deficiency* - Deficiency of gonadotropins (LH and FSH) can occur due to radiation damage to the **gonadotrophs**, leading to hypogonadism. - Symptoms often include **sexual dysfunction**, **infertility**, and changes in secondary sexual characteristics, which are not the primary complaints here. *ACTH deficiency* - **ACTH deficiency** due to radiation damage to the **corticotrophs** is possible but typically occurs later than growth hormone deficiency. - It can lead to **adrenal insufficiency** with symptoms like severe fatigue, weakness, hypotension, and electrolyte disturbances, which are more critical than the general symptoms described.

Q: A 60-year-old man is diagnosed with Conn's syndrome. What is the expected effect on his serum potassium levels?

Hypokalemia. ***Hypokalemia*** - **Conn's syndrome** (primary hyperaldosteronism) leads to excessive **aldosterone** secretion, which promotes potassium excretion in the kidneys [1]. - This increased renal potassium wasting results in **decreased serum potassium levels**, commonly presenting as hypokalemia [1], [2]. *Hyperkalemia* - **Hyperkalemia** (high potassium) is the opposite of what occurs in Conn's syndrome; conditions like **adrenal insufficiency** (Addison's disease) or renal failure are associated with hyperkalemia due to decreased aldosterone effect or inability to excrete potassium. - Conn's syndrome causes increased **aldosterone** activity, actively moving potassium out of the body [1]. *Normokalemia* - While some patients with primary hyperaldosteronism can initially present with **normokalemia**, sustained oversecretion of **aldosterone** typically leads to some degree of **potassium depletion** as the kidneys continue to excrete it [2]. - **Normokalemia** would not be the *expected* long-term effect in untreated Conn's syndrome. *Hypernatremia* - Conn's syndrome is characterized by increased **aldosterone** secretion, which primarily causes **sodium retention** and **potassium excretion** [1]. - While sodium retention occurs, it often leads to **volume expansion** and **suppression of ADH**, preventing significant **hypernatremia**; instead, patients often have normal or mildly elevated serum sodium levels [2].

Q: A 45-year-old woman is experiencing night sweats and tremors. Her laboratory results reveal elevated T3 and T4 levels. What is the most likely diagnosis?

Primary hyperthyroidism. ***Primary hyperthyroidism*** - The combination of **night sweats**, **tremors**, and **elevated T3 and T4 levels** is highly indicative of hyperthyroidism [3]. - In primary hyperthyroidism, the thyroid gland itself overproduces thyroid hormones, leading to increased levels of **T3** and **T4** and typically suppressed TSH (not provided, but implied) [2]. *Primary hypothyroidism* - This condition is characterized by **low T3 and T4 levels** and **elevated TSH**, which directly contradicts the patient's lab results [2]. - Clinical symptoms often include **fatigue**, **weight gain**, and **cold intolerance**, not night sweats and tremors [1]. *Secondary hypothyroidism* - This condition involves **low T3 and T4 levels** due to a pituitary or hypothalamic dysfunction, leading to low TSH, which is opposite to the patient's elevated thyroid hormones [4]. - Clinical presentation would also involve symptoms of thyroid hormone deficiency. *Secondary hyperthyroidism* - While this also causes **elevated T3 and T4**, it is due to an **overproduction of TSH** from the pituitary gland [4]. - This is a much rarer cause of hyperthyroidism compared to primary hyperthyroidism, and the lack of TSH information makes primary hyperthyroidism the most likely initial diagnosis given the common clinical presentation.

Q: What is the most effective lifestyle intervention for a patient with type 2 diabetes mellitus to manage hyperglycemia?

Weight loss. ***Weight loss*** - **Weight loss**, particularly in overweight or obese individuals with **type 2 diabetes**, significantly improves **insulin sensitivity** and reduces hyperglycemia [1]. - Even a modest weight reduction can lead to lower HbA1c levels and a decreased need for **antidiabetic medications** [2]. *Increased dietary fiber* - While **dietary fiber** can help improve glycemic control by slowing glucose absorption and promoting satiety, it is generally less effective than overall weight loss for managing significant hyperglycemia [1]. - Its primary benefits often revolve around improving **lipid profiles** and **bowel function**, which are secondary to direct glucose lowering. *Low-intensity exercise* - **Low-intensity exercise** is beneficial for overall health and can slightly improve glucose uptake by muscles, but its impact on substantial hyperglycemia management is limited compared to more vigorous activity or significant weight loss [1]. - To achieve significant glycemic benefits, a combination of **aerobic** and **resistance training** is often recommended alongside dietary changes. *Supplemental niacin* - **Niacin** (Vitamin B3) can improve **lipid profiles**, particularly by raising HDL cholesterol, but it is known to potentially *worsen* **insulin resistance** and **hyperglycemia** in some diabetic patients. - Therefore, it is generally not a recommended intervention for managing **hyperglycemia** in **type 2 diabetes**.

Q: A 70-year-old woman presents with a severe headache and visual disturbances. An MRI shows a pituitary mass that stains positive for ACTH. Which endocrine disorder is consistent with this presentation?

Corticotroph adenoma. ***Corticotroph adenoma*** - A pituitary mass that stains positive for **ACTH (adrenocorticotropic hormone)** is characteristic of a corticotroph adenoma. - This type of adenoma leads to **Cushing's disease** due to excessive ACTH production, which stimulates the adrenal glands to produce cortisol [1]. - The most common local complication of a large pituitary tumour is compression of the optic pathway, often resulting in visual disturbances [1]. *Prolactinoma* - A prolactinoma would stain positive for **prolactin**, not ACTH. - Clinical symptoms typically include **galactorrhea** and **amenorrhea** in women, or **hypogonadism** in men. *Somatotroph adenoma* - A somatotroph adenoma would stain positive for **growth hormone (GH)**, not ACTH. - It causes **acromegaly** in adults or gigantism in children, presenting with distinct physical changes rather than features of cortisol excess. *Thyrotroph adenoma* - A thyrotroph adenoma would stain positive for **thyroid-stimulating hormone (TSH)**, not ACTH. - This condition is rare and can lead to **hyperthyroidism** due to excess TSH production, with symptoms related to thyroid hormone excess.

Q: Which hormone imbalance is primarily responsible for the development of Cushing's syndrome?

Excess cortisol. ***Excess cortisol*** - **Cushing's syndrome** is fundamentally caused by prolonged exposure to inappropriately high levels of **glucocorticoids**, primarily **cortisol** [1], [3]. - This excess can stem from various sources, including endogenous overproduction (e.g., adrenal tumors) or exogenous administration (e.g., corticosteroid medications) [1], [2]. *Deficiency of aldosterone* - A deficiency in **aldosterone** is characteristic of conditions like **Addison's disease** or congenital adrenal hyperplasia, which involve adrenal insufficiency. - This leads to symptoms such as **hyponatremia**, **hyperkalemia**, and **hypotension**, directly opposite to the clinical picture of Cushing's syndrome. *Deficiency of insulin* - A deficiency in **insulin** is the hallmark of **Type 1 diabetes mellitus**, leading to **hyperglycemia** and metabolic dysfunction. - While patients with Cushing's syndrome can develop **invsulin resistance** and glucose intolerance due to high cortisol, the primary underlying hormonal imbalance for the syndrome itself is not insulin deficiency. *Excess thyroid hormone* - **Excess thyroid hormone** is responsible for **hyperthyroidism** (e.g., Graves' disease), leading to symptoms like **tachycardia**, **weight loss**, and **heat intolerance**. - These symptoms are distinct from the classic features of Cushing's syndrome, which include weight gain, central obesity, and moon facies [2].

Q: A 45-year-old woman presents with episodes of severe headache, palpitations, and sweating, with consistently high blood pressure during these episodes. What is the most likely diagnosis?

Pheochromocytoma. ***Pheochromocytoma*** - The classic triad of **severe headache, palpitations, and sweating**, especially when episodic and associated with **hypertensive crises**, is highly suggestive of a pheochromocytoma. - This tumor often secretes **catecholamines**, leading to these paroxysmal symptoms and sustained or episodic hypertension. *Migraine* - While migraines cause severe headaches, they are usually **unilateral** and often accompanied by **photophobia, phonophobia, and aura**, not episodic hypertension, palpitations, or profuse sweating. [1] - **Blood pressure changes** during a migraine are typically secondary and not the prominent, paroxysmal elevations seen here. *Cluster headache* - Characterized by **excruciating, unilateral pain** around the eye or temple, often accompanied by **lachrymation, ptosis, and rhinorrhea**, and occurs in clusters [2]. - It does **not typically present with hypertension, palpitations, or generalized sweating** as primary symptoms. *Temporal arteritis* - This condition presents with a **new-onset headache in an older adult**, often with **scalp tenderness, jaw claudication, and visual disturbances**. - It is an **inflammatory vasculitis** and does not cause episodic palpitations, sweating, or paroxysmal hypertension. [1]

Q: Which of the following is the most appropriate initial management for a patient with diabetic ketoacidosis (DKA)?

Intravenous insulin infusion. ***Intravenous insulin infusion*** - **Intravenous insulin** is crucial in DKA to reverse gluconeogenesis, glycogenolysis, and ketogenesis, rapidly lowering blood glucose and resolving acidosis [1]. - An initial **bolus** followed by a continuous infusion ensures a steady and predictable reduction in glucose and ketone levels. *Oral metformin* - **Metformin** works by decreasing hepatic glucose production and increasing insulin sensitivity, which is too slow and ineffective in the acute crisis of DKA. - It is contraindicated in conditions leading to **renal impairment** or metabolic acidosis, both of which can be present or exacerbated in DKA. *Subcutaneous long-acting insulin* - **Long-acting insulin**, while essential for basal insulin replacement in diabetes management, acts too slowly to address the acute metabolic derangements of DKA. - Starting with long-acting insulin alone would **delay correction** of severe hyperglycemia and ketosis [2]. *Oral sulfonylureas* - **Sulfonylureas** stimulate insulin secretion from pancreatic beta cells, which are already severely dysfunctional or exhausted in DKA [3]. - These medications can also cause **hypoglycemia** and are not designed for the magnitude of hyperglycemia seen in DKA [3].

Q: A 65-year-old woman with a history of osteoporosis presents with a vertebral compression fracture. Which of the following is the most appropriate long-term management?

Imaging assessment (MRI/CT). ***Imaging assessment (MRI/CT)*** - **MRI or CT imaging** is crucial for long-term management to precisely determine the extent of the **vertebral compression fracture**, identify the **number of affected vertebrae**, and detect any potential **spinal cord compression** or instability. - This information guides further interventions, including **vertebroplasty**, **kyphoplasty**, or **surgical stabilization**, and helps monitor the progression or healing of the fracture, especially in cases of **osteoporosis** [1]. *Neurological assessment* - While important in the **acute phase** to rule out immediate neurological compromise, a neurological assessment alone is not a long-term management strategy for the fracture itself [1]. - It helps guide initial treatment but does not address the underlying bone health or fracture mechanics. *Early mobilization as tolerated* - **Early mobilization** is crucial for preventing deconditioning and complications, but it is a rehabilitation strategy, not a primary long-term management for the fracture itself without prior assessment. - The type and extent of mobilization need to be guided by imaging and further medical assessment to prevent further damage [1]. *Pain management with analgesics* - **Pain management** is a symptomatic treatment and an important part of the immediate and ongoing care. - However, it does not address the underlying **pathology (osteoporosis)** or the **structural integrity of the spine**, which is critical for long-term management [1].

Question 1

A 63-year-old female with a history of osteoporosis presents with worsening back pain and weight loss. MRI shows multiple vertebral fractures and compression deformities. Which treatment option is most appropriate for this patient?

Accepted Answer

Initiate bisphosphonates to reduce further bone loss

Answer

Calcium and vitamin D supplementation, defer further treatment

Answer

Spinal surgery, then reassess bone health

Answer

Start anabolic agents like teriparatide to build bone mass

Question 2

A patient with a history of radiation exposure presents with fatigue and weight loss. Which hormone deficiency is most commonly associated with cranial radiation therapy?

Accepted Answer

Growth hormone deficiency

Answer

Prolactin deficiency

Answer

Gonadotropin deficiency

Answer

ACTH deficiency

Question 3

A 60-year-old man is diagnosed with Conn's syndrome. What is the expected effect on his serum potassium levels?

Accepted Answer

Hypokalemia

Answer

Hyperkalemia

Answer

Normokalemia

Answer

Hypernatremia

Question 4

A 45-year-old woman is experiencing night sweats and tremors. Her laboratory results reveal elevated T3 and T4 levels. What is the most likely diagnosis?

Accepted Answer

Primary hyperthyroidism

Answer

Primary hypothyroidism

Answer

Secondary hypothyroidism

Answer

Secondary hyperthyroidism

Question 5

What is the most effective lifestyle intervention for a patient with type 2 diabetes mellitus to manage hyperglycemia?

Accepted Answer

Weight loss

Answer

Increased dietary fiber

Answer

Low-intensity exercise

Answer

Supplemental niacin

Question 6

A 70-year-old woman presents with a severe headache and visual disturbances. An MRI shows a pituitary mass that stains positive for ACTH. Which endocrine disorder is consistent with this presentation?

Accepted Answer

Corticotroph adenoma

Answer

Prolactinoma

Answer

Somatotroph adenoma

Answer

Thyrotroph adenoma

Question 7

Which hormone imbalance is primarily responsible for the development of Cushing's syndrome?

Accepted Answer

Excess cortisol

Answer

Deficiency of aldosterone

Answer

Deficiency of insulin

Answer

Excess thyroid hormone

Question 8

A 45-year-old woman presents with episodes of severe headache, palpitations, and sweating, with consistently high blood pressure during these episodes. What is the most likely diagnosis?

Accepted Answer

Pheochromocytoma

Answer

Migraine

Answer

Cluster headache

Answer

Temporal arteritis

Question 9

Which of the following is the most appropriate initial management for a patient with diabetic ketoacidosis (DKA)?

Accepted Answer

Intravenous insulin infusion

Answer

Oral metformin

Answer

Subcutaneous long-acting insulin

Answer

Oral sulfonylureas

Question 10

A 65-year-old woman with a history of osteoporosis presents with a vertebral compression fracture. Which of the following is the most appropriate long-term management?

Accepted Answer

Imaging assessment (MRI/CT)

Answer

Early mobilization as tolerated

Answer

Neurological assessment

Answer

Pain management with analgesics

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?